TickerGuard
Buy Day today: Good (67) Broad market participation · no major macro event

Recursion Pharmaceuticals Inc (RXRX)

Healthcare Biotechnology
3.20 $
+6.0% vs. previous close
Closing price · As of: 3. Aug 2026

Recursion Pharmaceuticals Inc (RXRX) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q1 26), "Total Assets" came in at 1,340 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow
Annual Quarterly

All figures in millions of USD.

Balance Sheet RXRX
Tick rows to compare them in a chart (up to 4) Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26
667 631 654 558 776 726 1,449 1,305 1,302 1,400 1,474 1,340
431 411 438 344 522 474 714 584 587 714 813 710
406 387 392 300 474 428 594 500 528 660 743 654
406 387 392 300 474 428 594 500 528 660 743 654
3.1 3.2 3.1 2.6 2.5 2.3 49 46 22 22 25 14
3.3 2.3 – – – – – – – – – –
90 – – – – – – – – – – –
61 53 52 52 52 52 149 158 164 162 162 160
43 39 36 33 38 34 336 336 341 322 310 294
198 193 190 157 191 202 414 371 383 353 343 315
114 94 93 74 86 109 187 142 164 155 148 130
5.9 6.1 6.2 6.1 17 16 22 20 20 20 22 22
2.1 4.3 4.0 5.1 3.8 2.3 22 25 19 14 18 20
1.2 1.1 1.1 1.1 23 21 19 16 14 12 9.6 7.2
469 438 463 401 584 525 1,035 934 919 1,047 1,131 1,025
-782 -875 -968 -1,059 -1,157 -1,252 -1,431 -1,634 -1,806 -1,968 -2,076 -2,194
201 214 233 236 242 283 336 403 417 447 527 529

Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?